glp-1 agonists in development Receptor and Research to Treat Overeating and Substance Use Disorders Glucagon-like peptide-1 receptor: mechanisms and
Description
Commonly considered an undesirable off-target for molecular glue degrader programs, GSPT1 is emerging as a promising oncology target

are uncompensated consultants for Pfizer

GLP-1 inhibits high-glucose-induced oxidative injury of vascular endothelial cells

Modern sulphonylureas and cardiovascular adverse effects: will CAROLINA put an end to the controversy

All kidney injury cases were associated with severe dehydration from vomiting or diarrhea
